Scenarios that move BIIB
Biogen Inc. - Common Stock
Scenarios that move BIIB: 4 analyses, 4 positive, 0 negative.
- · Satellos wins FDA IND clearance for Forazapadin in FSHD — ▲ · impact +20 · confidence low · horizon weeks
- · Ionis reports positive late-stage results for two partnered drugs — ▲ · impact +59 · confidence medium · horizon immediate
- · Xenon files epilepsy NDA as depression study setback weighs — ▲ · impact +12 · confidence low · horizon quarters
- · FDA approves Isembyld for spinal muscular atrophy treatment — ▲ · impact +42 · confidence low · horizon weeks